Mapping the effectiveness and risks of GLP-1 receptor agonists.
Xie Y, Choi T, Al-Aly Z.
Nat Med. 2025 Mar;31(3):951-962. doi: 10.1038/s41591-024-03412-w. Epub 2025 Jan 20.
Life of a Type 1 diabetic.
Kilbreath A.
Fam Syst Health. 2024 Dec;42(4):649-650. doi: 10.1037/fsh0000907. Epub 2024 Jul 25.
Dementia in Diabetes: The Role of Hypoglycemia.
Husain KH, Sarhan SF, AlKhalifa HKAA, Buhasan A, Moin ASM, Butler AE.
Int J Mol Sci. 2023 Jun 7;24(12):9846. doi: 10.3390/ijms24129846.
Insulin use: preventable errors.
Prescrire Editorial Staff.
Prescrire Int. 2014 Jan;23(145):14-7.
[Seizures and non-ketotic hyperglycemia].
Scherer C.
Presse Med. 2005 Sep 10;34(15):1084-6. doi: 10.1016/s0755-4982(05)84123-5.
Tirzepatide associated autoimmune encephalitis: A case report.
Abdi A, Ariaei A, Hemasian H, Shahabi S, Sina F.
J Am Pharm Assoc (2003). 2025 Sep-Oct;65(5):102474. doi: 10.1016/j.japh.2025.102474. Epub 2025 Jul 1.
Envisioning the neuroprotective effect of Metformin in experimental epilepsy: A portrait of molecular crosstalk.
H S N, Paudel YN, K L K.
Life Sci. 2019 Sep 15;233:116686. doi: 10.1016/j.lfs.2019.116686. Epub 2019 Jul 23.
Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.
Frier BM.
Nat Rev Endocrinol. 2014 Dec;10(12):711-22. doi: 10.1038/nrendo.2014.170. Epub 2014 Oct 7.
The Anti-Seizure Effect of Liraglutide on Ptz-Induced Convulsions Through its Anti-Oxidant and Anti-Inflammatory Properties.
Erdogan MA, Erdogan A, Erbas O.
Neurochem Res. 2023 Jan;48(1):188-195. doi: 10.1007/s11064-022-03736-4. Epub 2022 Aug 30.
Topiramate and type 2 diabetes: an old wine in a new bottle.
Khanna V, Arumugam S, Roy S, Mittra S, Bansal VS.
Expert Opin Ther Targets. 2008 Jan;12(1):81-90. doi: 10.1517/14728222.12.1.81.
